Molecular Mechanisms of Combination Adjuvants (MMCA) (R01 Clinical Trial Not Allowed)
This grant opportunity supports research on how two or more vaccine adjuvants work together to enhance immune response. The aim is to understand their mechanisms and ultimately create better vaccines by predicting how these combinations will affect the immune system. Eligible adjuvants must have previously shown that they can modify immune activity.
Source
Dates
Keywords
Supporting Links
Documents
Similar Opportunities
-
NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed)
National Institutes of Health
-
DoW Autism Clinical Trial Award
Dept. of the Army -- USAMRAA
-
Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)
National Institutes of Health
-
Multiple Sclerosis Fellowship (Minnesota)
Mayo Clinic
-
NIA Academic Leadership Career Award (K07 Independent Clinical Trial Not Allowed)
National Institutes of Health
Find tens of thousands more opportunities — free
Scout accounts are free. Sign up to browse the full funding database, unlock the solicitation links and documents for this opportunity, and see how well each one fits your organization.
-
Tens of thousands of funding opportunities
Search and filter every grant and solicitation in Scout — all free, no credit card required.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Save opportunities & track deadlines
Keep the opportunities that fit in one place and stay ahead of every due date.
Already have an account? Sign In
Trusted by 500+ Happy Customers